ClearPoint Neuro, Inc.

CLPT

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-094131
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Sell

Net shares

-4,506

% of shares

-5.55%

Amount (USD)

$39,833

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+8,856.0

Acquired/Disposed

Acquired

Shares Owned Before

72,356.0

Shares Owned After

81,212.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-4,506.0

Price per Share

$8.84

Amount (USD)

$39,833.04

Acquired/Disposed

Disposed

Shares Owned Before

81,212.0

Shares Owned After

76,706.0

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-8,856.0

Acquired/Disposed

Disposed

Shares Owned Before

44,280.0

Shares Owned After

35,424.0

Filing's footnotes

1. Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (&quot;CLPT&quot;) common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

2. Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.